ARKK Investment Tracker position change: Decreased position in Pacific Biosciences of California by 360,624 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.33% of the total position.
ARKK Investment Tracker position change: Decreased position in Snowflake by 3,872 shares, the number of shares held decreased 2.61% compared to the previous period and now represents 0.57% of the total position.
ARKK Investment Tracker position change: Decreased position in Figma by 42,680 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.51% of the total position.
ARKK Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 28,512 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.88% of the total position.
ARKK Investment Tracker position change: Decreased position in Alphabet by 2,376 shares, the number of shares held decreased 2.59% compared to the previous period and now represents 0.54% of the total position.
ARKK Investment Tracker position change: Decreased position in Meta Platforms, Inc. by 2,728 shares, the number of shares held decreased 2.6% compared to the previous period and now represents 0.99% of the total position.
ARKK Investment Tracker position change: Decreased position in BWX Technologies Inc by 7,172 shares, the number of shares held decreased 2.62% compared to the previous period and now represents 0.96% of the total position.
ARKK Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 3,740 shares, the number of shares held decreased 2.62% compared to the previous period and now represents 1.07% of the total position.
ARKK Investment Tracker position change: Decreased position in SoFi Technologies Inc. by 53,152 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.59% of the total position.
ARKK Investment Tracker position change: Decreased position in Eli Lilly by 792 shares, the number of shares held decreased 2.61% compared to the previous period and now represents 0.58% of the total position.
ARKK Investment Tracker position change: Decreased position in GeneDx Holdings by 24,640 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 1.01% of the total position.
ARKK Investment Tracker position change: Decreased position in Roku Inc by 47,543 shares, the number of shares held decreased 12.68% compared to the previous period and now represents 0.78% of the total position.
ARKK Investment Tracker position change: Decreased position in X-Energy by 62,700 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.77% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 275,194 shares, the number of shares held increased 2.36% compared to the previous period and now represents 2.64% of the total position.
ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 4,009 shares, the number of shares held increased 0.13% compared to the previous period and now represents 2.66% of the total position.
ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 553 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1.85% of the total position.
ARKG Investment Tracker position change: Increased position in Veracyte by 1,160 shares, the number of shares held increased 0.13% compared to the previous period and now represents 3.47% of the total position.
ARKG Investment Tracker position change: Increased position in Eli Lilly by 7,331 shares, the number of shares held increased 24.53% compared to the previous period and now represents 2.85% of the total position.
ARKK Investment Tracker position change: Decreased position in Pacific Biosciences of California by 360,624 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.33% of the total position.
ARKK Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 28,512 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.88% of the total position.
ARKK Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 3,740 shares, the number of shares held decreased 2.62% compared to the previous period and now represents 1.07% of the total position.
ARKX Investment Tracker position change: Decreased position in Kratos Defense & Security Solutions by 18,620 shares, the number of shares held decreased 1.77% compared to the previous period and now represents 7.08% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 275,194 shares, the number of shares held increased 2.36% compared to the previous period and now represents 2.64% of the total position.
ARKK Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 522,720 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 1.09% of the total position.
ARKX Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 620 shares, the number of shares held decreased 1.76% compared to the previous period and now represents 2.18% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 13,172 shares, the number of shares held increased 0.13% compared to the previous period and now represents 1% of the total position.
ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 2,463 shares, the number of shares held increased 0.13% compared to the previous period and now represents 2.51% of the total position.
ARKK Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 37,356 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 2.73% of the total position.
ARKX Investment Tracker position change: Decreased position in L3Harris Technologies, Inc. by 3,810 shares, the number of shares held decreased 1.77% compared to the previous period and now represents 8.7% of the total position.
ARKX Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 3,650 shares, the number of shares held decreased 1.77% compared to the previous period and now represents 3.29% of the total position.
ARKK Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 171,116 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 3.74% of the total position.
ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 51,542 shares, the number of shares held increased 10.45% compared to the previous period and now represents 0.61% of the total position.
ARKK Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 158,532 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 5.47% of the total position.
ARKK Investment Tracker position change: Decreased position in Intellia Therapeutics by 302,368 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 3.02% of the total position.
ARKK Investment Tracker position change: Decreased position in SoFi Technologies Inc. by 53,152 shares, the number of shares held decreased 2.63% compared to the previous period and now represents 0.59% of the total position.
ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 2,657 shares, the number of shares held increased 0.13% compared to the previous period and now represents 4.74% of the total position.
ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 2,527 shares, the number of shares held increased 0.13% compared to the previous period and now represents 7.13% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 27,709 shares, the number of shares held decreased 1.82% compared to the previous period and now represents 9.33% of the total position.